Summit Financial, LLC Amgen Inc Transaction History

Summit Financial, LLC

$2.18 Billion
Q2 2024

A detailed history of Summit Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Summit Financial, LLC holds 6,137 shares of AMGN stock, worth $1.94 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,137

Previous 2,978 106.08%

Holding current value

$1.94 Million

Previous $846,000 126.6%

% of portfolio

0.09%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $830,027 - $1.01 Million	3,159 Added 106.08%	6,137 $1.92 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.17%	2,978 $846,000
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $5,114 - $5,769	20 Added 0.68%	2,973 $856,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $739,911 - $918,620	-3,384 Reduced 53.4%	2,953 $793,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $204,627 - $241,968	955 Added 17.74%	6,337 $1.41 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $55,544 - $67,699	246 Added 4.79%	5,382 $1.3 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $39,393 - $50,053	172 Added 3.46%	5,136 $1.35 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $251,844 - $284,034	1,122 Added 29.2%	4,964 $1.12 Billion
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $54,216 - $60,333	235 Added 6.52%	3,842 $934,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $99,329 - $109,884	453 Added 14.36%	3,607 $872,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $182,571 - $208,936	918 Added 41.06%	3,154 $709,000
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $230,525 - $270,088	1,086 Added 94.43%	2,236 $475,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $268,617 - $298,011	1,150 New	1,150 $280,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.

Account

Summit Financial, LLC Amgen Inc Transaction History